Skip to main content

Clinical trials

  • Target-CD

    Crohn's disease (CD) is a long-lasting disease that causes severe inflammation (redness, swelling), in the digestive tract, most frequently affecting the bowels. It can cause many different symptoms including belly pain, diarrhea, tiredness, and…

    Investigator
    Angela Pham
    Ages
    18 Years - 75 Years
    Sexes
    All
  • Palekona-GS-US-457-6411

    The goal of this study is to learn if tilpisertib fosmecarbil (formerly known as GS-5290) is effective and safe in treating participants with moderate to severe ulcerative colitis. The study will compare participants in different treatment groups…

    Investigator
    Angela Pham
    Ages
    18 Years - 75 Years
    Sexes
    All
  • Restore

    This research study is testing an investigational research product called TRX103 as a possible treatment for individuals suffering from Crohn's Disease (CD). The primary purpose of this study is to learn how safe and effective different doses of…

    Investigator
    Angela Pham
    Ages
    18 Years - 65 Years
    Sexes
    All
  • CorEvitas-IBD-600

    This prospective, non-interventional research registry is designed to study the comparative effectiveness and comparative safety of approved treatments for IBD in a cohort of patients cared for by gastroenterologists across North America. Secondary…

    Investigator
    Angela Pham
    Ages
    18 Years - N/A
    Sexes
    All
  • Saturn

    The SATURN trial aims to determine whether continuation vs. discontinuation of statin drugs after spontaneous lobar intracerebral hemorrhage (ICH) is the best strategy; and whether the decision to continue/discontinue statins should be influenced by…

    Investigator
    Anna Y Khanna
    Ages
    50 Years - N/A
    Sexes
    All
  • FASTEST Trial

    The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is…

    Investigator
    Anna Y Khanna
    Ages
    18 Years - 80 Years
    Sexes
    All